By Associate Professor Megan Amanda Crumbaker

Preprints

Emmett L; Swiha M; Papa N; Subramaniam S; Crumbaker M; Joshua A; Nguyen A; Weickhardt A; Lee S-T; Ng S; Francis R; Goh J; Pattison D; Pathmanandavel S; Ayati N; Hofman M; Sandhu S; Martin A; Thomas H; Stockler M; Davis I, 2025, Association of early PSMA upregulation with duration of response to enzalutamide with or without [177Lu]Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: Findings from the randomised, phase 2, ENZA-p trial (ANZUP 1901), http://dx.doi.org/10.21203/rs.3.rs-6307229/v1

Back to profile page